Kimberly Rieger‐Christ

Author

Also Known As

Chantal Reyna, Charles Saller, K M Rieger-Christ, K Rieger-Christ, K. M. Rieger-Christ, K. Rieger-Christ, KIMBERLY M. RIEGER-CHRIST, KIMBERLY RIEGER-CHRIST, Kimberly Christ, Kimberly M Rieger-Christ

184

Publications

12.2K

Citations

H-Index

Concepts

All Affiliations

Lahey Hospital and Medical Center Lahey Medical Center Tufts University Tufts Medical Center Boston University

About

Kimberly Rieger‐Christ is an author at Lahey Hospital and Medical Center specializing in medicine, tumor biology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	26	6.3K
2	Engineering	5	5	223
3	Health Sciences	1	1	16
4	Public Health	1	1	40
5	Biomedical Engineering	1	1	28

Kimberly Rieger‐Christ

Publications

9.2K

Citations

H-Index

Page 1

	Year	Citations
The Molecular Taxonomy of Primary Prostate Cancer Adam Abeshouse, Jaeil Ahn, Rehan Akbani, Cell UrologyGenitourinary CancerMedicinePathologyPrimary Prostate Cancer	2015	3.1K
Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma Benjamin J. Raphael, Ralph H. Hruban, Andrew J. Aguirre, Cancer Cell Functional GenomicsPancreatic CancerPathologyCancer GenomicsPancreatic Ductal Adenocarcinoma	2017	2K
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA M.C. Liu, Geoffrey R. Oxnard, Eric A. Klein, Annals of Oncology	2020	1.4K
Clinical Validation of an Epigenetic Assay to Predict Negative Histopathological Results in Repeat Prostate Biopsies Alan W. Partin, Leander Van Neste, Eric A. Klein, The Journal of Urology	2014	221
Suppression of Wnt Signaling by the Green Tea Compound (–)-Epigallocatechin 3-Gallate (EGCG) in Invasive Breast Cancer Cells Jiyoung Kim, Xiaowei Zhang, Kimberly Rieger‐Christ, Journal of Biological Chemistry Chemoprevention StrategyWnt SignalingCancer BiologyTumor BiologyTranscriptional Regulation	2006	201
Identification and Prognostic Significance of an Epithelial-Mesenchymal Transition Expression Profile in Human Bladder Tumors Egbert Baumgart, Michael S. Cohen, Brasil Silva Neto, Clinical Cancer Research	2007	192
Isocitrate Dehydrogenase Mutations Confer Dasatinib Hypersensitivity and SRC Dependence in Intrahepatic Cholangiocarcinoma Supriya K. Saha, John D. Gordan, Benjamin P. Kleinstiver, Cancer Discovery	2016	158
A MicroRNA expression profile defining the invasive bladder tumor phenotype Matthew Wszolek, Kimberly Rieger‐Christ, Patrick A. Kenney, Urologic Oncology Seminars and Original Investigations UrologyGenitourinary CancerPathologyCancer GenomicsSmall Rna	2009	117
A microRNA expression ratio defining the invasive phenotype in bladder tumors Lori A. Neely, Kimberly Rieger‐Christ, Brasil Silva Neto, Urologic Oncology Seminars and Original Investigations Bladder TumorsUrologyGenitourinary CancerMedicinePathology	2008	104
Identification of fibroblast growth factor receptor 3 mutations in urine sediment DNA samples complements cytology in bladder tumor detection Kimberly Rieger‐Christ, Arthur Mourtzinos, Peter J. Lee, Cancer	2003	101

Page 1